Commission Implementing Regulation (EU) 2020/2002Show full title

ANNEX I U.K. LISTED DISEASES SUBJECT TO UNION NOTIFICATION

1. Listed diseases of terrestrial animals subject to Union notification in accordance with point (a) of Article 3(1) and point (a) of Article 3(2) U.K.

• Foot and mouth disease

• Infection with rinderpest virus

• Infection with Rift Valley fever virus

• Infection with lumpy skin disease virus

• Infection with Mycoplasma mycoides subsp. mycoides SC (Contagious bovine pleuropneumonia)

• Sheep pox and goat pox

• Infection with peste des petits ruminants virus

• Contagious caprine pleuropneumonia

• African horse sickness

• Infection with Burkholderia mallei (Glanders)

• Classical swine fever

• African swine fever

• Highly pathogenic avian influenza

• Infection with Newcastle disease virus, excluding when diagnosed in:

  • Columbiformes unless kept as poultry; or

  • wild animals of listed species

• Infection with rabies virus

• Infection with epizootic haemorrhagic disease virus

• Anthrax

• Surra (Trypanosoma evansi)

• Ebola virus disease

• Equine infectious anaemia

• Dourine

• Venezuelan equine encephalomyelitis

• Infestation with Aethina tumida (Small hive beetle)

• Infestation with Tropilaelaps spp.

• Infection with Batrachochytrium salamandrivorans

• Japanese encephalitis

• West Nile fever

• Equine encephalomyelitis (Eastern and Western)

2. Listed diseases of aquatic animals subject to Union notification in accordance with point (a) of Article 3(1) and point (a) of Article 3(2) U.K.

• Epizootic haematopoietic necrosis

• Infection with Mikrocytos mackini

• Infection with Perkinsus marinus

• Infection with Taura syndrome virus

• Infection with yellow head disease virus

3. Listed diseases of terrestrial animals subject to Union notification in accordance with point (b) of Article 3(1) and point (b) of Article 3(2) U.K.

• Infection with Brucella abortus, B. melitensis, B. suis

• Infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae, M. tuberculosis) (MTBC)

• Infectious bovine rhinotracheitis/infectious pustular vulvovaginitis (IBR/IPV)

• Bovine viral diarrhoea (BVD)

• Enzootic bovine leukosis (EBL)

• Infection with Aujeszky’s disease virus (ADV)

4. Listed diseases of terrestrial animals subject to Union notification in accordance with point (c) of Article 3(1) and point (c) of Article 3(2) U.K.

• Infection with bluetongue virus (serotypes 1-24) (‘infection with BTV’) by serotype

• Infestation with Varroa spp.

• Infestation with Echinococcus multilocularis

5. Listed diseases of aquatic animals subject to Union notification in accordance with point (c) of Article 3(1) and point (c) of Article 3(2) U.K.

• Viral haemorrhagic septicaemia

• Infectious haematopoietic necrosis

• Infection with HPR deleted infectious salmon anaemia virus

• Infection with Marteilia refringens

• Infection with Bonamia exitiosa

• Infection with Bonamia ostreae

• Infection with white spot syndrome virus (‘infection with WSSV’)

ANNEX II U.K. INFORMATION TO BE PROVIDED FOR UNION NOTIFICATION ON OUTBREAKS OF LISTED DISEASES IN ACCORDANCE WITH ARTICLE 3(3)

1. Date of dispatch. U.K.

2. Time of dispatch. U.K.

3. Name of the country. U.K.

4. Name of disease and type of pathogen, where appropriate. U.K.

5. Serial number of outbreak. U.K.

6. Type of outbreak (primary/secondary outbreak). U.K.

7. Reference number of outbreak linked to this outbreak (where applicable). U.K.

8. Region and geographical location of the outbreak. U.K.

9. Date of suspicion. U.K.

10. Date of confirmation. U.K.

11. Diagnostic methods used. U.K.

12. Origin of disease. U.K.

13. Control measures taken. U.K.

14. Animals involved in the outbreak: U.K.

(a)

Terrestrial animals (by species) except honeybees and bumble bees:

(i)

number of susceptible animals, including wild animals where applicable;

(ii)

estimated number of clinically or subclinically infected or infested animals including wild animals, where applicable;

(iii)

estimated number of animals that have died or, in the case of wild animals, that have been found dead;

(iv)

number of animals killed;

(v)

number of animals slaughtered;

(b)

Honeybees and bumble bees:

(i)

number of susceptible colonies;

(ii)

number of clinically or subclinically infected or infested colonies;

(iii)

number of dead colonies;

(iv)

number of destroyed colonies;

(c)

Aquatic animals (by species):

(i)

estimated number or biomass of susceptible animals, including wild animals where applicable;

(ii)

estimated number or biomass of clinically or subclinically infected animals, including wild animals where applicable;

(iii)

estimated number or biomass of animals that have died or in the case of wild animals, that have been found dead;

(iv)

estimated number or biomass of animals killed;

(v)

estimated number or biomass of animals slaughtered.

15. Date of preliminary cleaning and disinfection (where applicable). U.K.

ANNEX III U.K. INFORMATION TO BE PROVIDED FOR UNION REPORTING ON THE DETECTION OF LISTED DISEASES IN ACCORDANCE WITH ARTICLE 4(3)

1. Date of report. U.K.

2. Reporting period. U.K.

3. Name of the country. U.K.

4. Name of disease and type of pathogen, where appropriate. U.K.

5. Number of outbreaks by listed animal species or group of species during the reporting period. U.K.

6. Date of confirmation of the last outbreak. U.K.

ANNEX IV U.K. REGIONS IN THE MEMBER STATES FOR THE PURPOSE OF NOTIFICATION AND REPORTING IN ACCORDANCE WITH ARTICLE 5

Member State:	Notification and reporting regions:
Belgium	province – provincie
Bulgaria	област
Czechia	okres
Denmark	veterinary units or municipalities
Germany	Kreis, Regierungsbezirk oder Bundesland
Estonia	maakond
Ireland	county
Greece	περιφερειακή ενότητα
Spain	provincia
France	département
Croatia	županija
Italy	provincia
Cyprus	επαρχία
Latvia	novads
Lithuania	apskritis
Luxembourg	entire country
Hungary	megye
Malta	entire country
Netherlands	gemeente
Austria	Bezirk
Poland	powiat
Portugal	mainland: distrito other parts of the territory: região autónoma
Romania	județ
Slovenia	območni urad
Slovakia	kraj
Finland	maakunta/landskap
Sweden	kommun

ANNEX V U.K. INFORMATION ON THE RESULTS OF THE IMPLEMENTATION OF COMPULSORY AND OPTIONAL ERADICATION PROGRAMMES TO BE PROVIDED IN ACCORDANCE WITH POINT A OF ARTICLE 7(2)

SECTION 1 U.K. Results of eradication programmes for category B and C diseases of terrestrial animals based on granting of disease-free status at the level of establishments

Information to be provided on eradication programmes for category B and C diseases of terrestrial animals based on granting of the disease-free status at the level of establishments:

1.

Date of report.

2.

Reporting period.

3.

Name of the country.

4.

Name of disease.

5.

Territorial scope (in the event of a change in the territorial scope in accordance with point 4 of Section 1 of Annex VII).

6.

Information on the establishments and animals concerned located in the territory in accordance with point 5, by zone or by region if more than one region is included in the territorial scope of the programme:

(a)

Number of establishments keeping animals of the targeted animal population excluding establishments falling under the derogation in accordance with Article 19 of Commission Delegated Regulation (EU) 2020/689(1) at 31 December;

(b)

Number of animals of the targeted animal population kept in the establishments referred to in point (a) at 31 December;

(c)

Number of establishments with disease-free status including establishments with suspended disease-free status, with vaccination or without vaccination, where relevant, out of the number of establishments referred to in point (a) at 31 December;

(d)

Number of animals kept in the establishments referred to in point (c);

(e)

Number of establishments with one or more confirmed cases out of the number of establishments referred to in point (a) at 31 December;

(f)

Number of outbreaks confirmed during the reporting period.

SECTION 2 U.K. Results of eradication programmes for infection with RABV

Information to be provided on eradication programmes for infection with RABV:

1.

Date of report.

2.

Reporting period.

3.

Name of the country.

4.

Territorial scope (in the event of a change in the territorial scope in accordance with point 3 of Section 2 of Annex VII).

5.

Information on surveillance per zone or region if more than one region is included in the territorial scope of the programme, including at least maps with data of:

(a)

Number of indicator animals tested per species;

(b)

Number of confirmed cases by species.

6.

Information on vaccination of wild animals, per zone or region if more than one region is included in the territorial scope of the programme:

(a)

Number and dates of vaccination campaigns;

(b)

Vaccine bait density achieved and, if the total size of the vaccination area per vaccination campaign is greater than 20 000 km², vaccine bait density maps;

(c)

Upon request of the Commission, electronic files containing:

(i)

Flight routes recorded during the vaccine bait distribution;

(ii)

Vaccine bait distribution (time and position of each bait released) recorded during aerial distribution if the total size of the vaccination area per vaccination campaign is greater than 20 000 km²;

(d)

Information on the monitoring of the effectiveness of the vaccination, with maps with data of:

(i)

number of animals positive to the biomarker test/number of biomarker tests performed;

(ii)

number of animals positive to serological tests/number of serological tests performed.

SECTION 3 U.K. Results of eradication programmes for infection with BTV

Information to be provided on eradication programmes for infection with BTV:

1.

Date of report.

2.

Reporting period.

3.

Name of the country.

4.

Territorial scope (in the event of a change in the territorial scope in accordance with point 3 of Section 3 of Annex VII).

5.

Information on surveillance in the territory in accordance with point 4, by zone or by region if more than one region is included in the territorial scope of the programme:

(a)

number of establishments keeping animals of the targeted animal population at 31 December;

(b)

number of animals of the targeted animal population kept in the establishments referred to in point (a) at 31 December;

(c)

number of establishments keeping animals of the targeted animal population where vaccination against infection with BTV has been carried out and number of animals vaccinated during the reporting period, by species and, if relevant, by serotypes of BTV;

(d)

number of outbreaks by BTV serotype confirmed during the reporting period;

(e)

number and location of vector protected establishments, where relevant;

(f)

description of seasonally BTV-free areas and dates of beginning and end of the vector-free period, where relevant.

SECTION 4 U.K. Results of eradication programmes for category B and C diseases of aquatic animals

Information to be provided on eradication programmes for category B and C diseases of aquatic animals:

1.

Date of report.

2.

Reporting period.

3.

Name of the country.

4.

Name of disease.

5.

Territorial scope (in the event of a change in the territorial scope in accordance with point 4 of Section 4 of Annex VII).

6.

Information on the aquaculture establishments and animals concerned located in the territory referred to in point 5 by compartment, zone or region, if more than one region is included in the territorial scope of the programme:

(a)

number of approved aquaculture establishments and number of registered aquaculture establishments keeping animals of the targeted animal population and, where relevant, sampling points in wild populations, which are included in the eradication programme, at 31 December;

(b)

number of aquaculture establishments and, where relevant, sampling points in wild populations, out of the number of establishments or sampling points referred to in point (a), which are not infected at 31 December;

(c)

number of infected aquaculture establishments and, where relevant, sampling points in wild populations with confirmed case(s) out of the number of establishments and sampling points referred to in point (a) at 31 December;

(d)

number of new infected aquaculture establishments and, where relevant, sampling points in wild populations, with confirmed case(s) out of the number of establishments and sampling points referred to in point (a) at 31 December.

ANNEX VI U.K. INFORMATION ON THE RESULTS OF THE IMPLEMENTATION OF COMPULSORY AND OPTIONAL ERADICATION PROGRAMMES TO BE PROVIDED IN ACCORDANCE WITH POINT B OF ARTICLE 7(2) AND INFORMATION TO BE INCLUDED IN APPLICATIONS FOR THE RECOGNITION OF DISEASE-FREE STATUS OF MEMBER STATES OR ZONES AS REGARDS DISEASES OF TERRESTRIAL AND AQUATIC ANIMALS AND IN APPLICATIONS FOR THE RECOGNITION OF DISEASE-FREE STATUS OF COMPARTMENTS AS REGARDS DISEASES OF AQUATIC ANIMALS IN ACCORDANCE WITH ARTICLE 11

SECTION 1 U.K. Compliance with general criteria

General information to be included in applications for the recognition of disease-free status:

1.

Date of application.

2.

Name of the country.

3.

Name of disease.

4.

Territorial scope as regards the recognition of disease-free status.

5.

Statement confirming that the relevant general criteria in accordance with point (a) of Article 66 of Delegated Regulation (EU) 2020/689 for Member States or zones, or with point (a) of Article 73(1) of that Delegated Regulation for aquatic compartments, are complied with.

SECTION 2 U.K. Disease-free status based on the absence of listed species

Information to be included in applications for the recognition of disease-free status based on the absence of listed species:

Documentation in accordance with Articles 67(2) or 74(2) of Delegated Regulation (EU) 2020/689.

SECTION 3 U.K. Disease-free status based on the disease agent’s incapacity to survive

Information to be included in applications for the recognition of disease-free status based on the disease agent’s incapacity to survive:

Documentation in accordance with Articles 68(2) or 75(2) of Delegated Regulation (EU) 2020/689.

SECTION 4 U.K. Disease-free status based on the incapacity to survive of listed vectors for listed diseases of terrestrial animals

Information to be included in applications for the recognition of disease-free status based on the incapacity to survive of listed vectors for listed diseases of terrestrial animals:

Documentation in accordance with Article 69(2) of Delegated Regulation (EU) 2020/689.

SECTION 5 U.K. Disease-free status based on historical and surveillance data

1. Information to be included by the competent authority in applications for the recognition of disease-free status based on historical and surveillance data, provided the disease has never been reported in the territory concerned or it has been eradicated and not reported for at least 25 years prior to the application for the recognition of disease-free status in that territory: U.K.

(a)

if recognition of the status free from infestation with Varroa spp. is requested:

documented evidence on the fulfilment of the requirements set out in points (a) to (f) of Section 1 of Part III of Annex V to Delegated Regulation (EU) 2020/689;

(b)

if recognition of the status free from infection with Bonamia exitiosa is requested:

(i)

the results of a survey conducted for at least one year in all establishments or groups of establishments keeping listed species within the Member State, zone or compartment, and where required, sampling points in wild populations. They must have been tested using a sample size that allows detection of infection with Bonamia exitiosa with a 95 % level of confidence, if the disease agent is present in the population at a prevalence rate of 2 %;

(ii)

measures applied to prevent the introduction of Bonamia exitiosa into the territory concerned;

(iii)

disease control measures applied in the event of an outbreak;

(c)

if recognition of the status free from infection with WSSV is requested:

(i)

the results of a survey conducted for at least one year in all establishments or groups of establishments keeping listed species within the Member State, zone or compartment, and where required, sampling points in wild populations. They must have been tested using a sample size that allows detection of infection with WSSV with a 95 % level of confidence, if the disease agent is present in the population at a prevalence rate of 2 %;

(ii)

measures applied to prevent the introduction of WSSV into the territory concerned;

(iii)

disease control measures applied in the event of an outbreak.

2. Information covering at least the previous 10 years to be included in applications for the recognition of the status free from BVD based on historical and surveillance data, when it has been reported in the past 25 years and it has been eradicated from the territory concerned: U.K.

(a)

number of establishments keeping bovine animals by health status(2) and number of bovine animals kept in these establishments at 31 December of each year;

(b)

testing strategy/regimes and diagnostic methods used to determine the BVD-status of the establishments keeping bovine animals (infected, non-infected);

(c)

testing strategy/regimes and diagnostic methods used to prove the maintenance of the non-infected status of establishments keeping bovine animals;

(d)

measures to prevent the introduction of BVD virus into the territory concerned;

(e)

disease control measures applied in the event of an outbreak;

(f)

number of outbreaks per year;

(g)

number of confirmed cases during the previous 18 months;

(h)

vaccination history and date of prohibition of vaccination against BVD for kept bovine animals.

3. Information to be included in applications for the recognition of disease-free status based on historical and surveillance data if recognition of the status free from infection with Newcastle disease virus infection without vaccination is requested: U.K.

documented evidence on the fulfilment of the requirements set out in points (a) to (e) of Section 1 of Part IV of Annex V to Delegated Regulation (EU) 2020/689.

SECTION 6 U.K. Disease-free status based on eradication programmes

Information to be included in applications for the recognition of disease-free status based on eradication programmes, by calendar year:

1.

in case of eradication programmes for infection with Brucella abortus, B. melitensis and B. suis as regards kept bovine animals by zone or region, if more than one region is included in the territorial scope of the programme:

(a)

number of establishments keeping bovine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 and number of bovine animals kept in these establishments at 31 December;

(b)

number of establishments keeping bovine animals with the status free from infection with Brucella abortus, B. melitensis and B. suis with vaccination or without vaccination including establishments with suspended disease-free status and number of bovine animals kept in these establishments at 31 December;

(c)

number of establishments keeping bovine animals tested annually with a serological test for the granting or for the maintenance of the status and number of bovine animals tested;

(d)

number of establishments with suspicion following the testing referred to in point (c);

(e)

number of bovine animals introduced into an establishment referred to in point (a);

(f)

number of bovine animals tested with a serological test in the context of their introduction into an establishment;

(g)

number of establishments with suspicion following the testing referred to in point (f);

(h)

number of establishments confirmed infected among those referred in points (d) and (g);

(i)

number of establishments with investigations for abortions cases that may have been caused by infection with Brucella abortus, B. melitensis and B. suis;

(j)

number of establishments confirmed infected among those referred in point (i);

(k)

total number of establishments confirmed infected if different from the sum of those reported in points (h) and (j);

(l)

date of last vaccination against infection with Brucella abortus, B. melitensis and B. suis of kept bovine animals;

(m)

number of establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 and number of bovine animals kept in these establishments at 31 December;

2.

in case of eradication programmes for infection with Brucella abortus, B. melitensis and B. suis as regards kept ovine and caprine animals, by zone or region, if more than one region is included in the territorial scope of the programme:

(a)

number of establishments keeping ovine or caprine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 and number of ovine or caprine animals kept in these establishments at 31 December;

(b)

number of establishments keeping ovine or caprine animals with the status free from infection with Brucella abortus, B. melitensis and B. suis with or without vaccination including establishments with suspended disease-free status and number of ovine or caprine animals kept in these establishments at 31 December;

(c)

number of establishments keeping ovine or caprine animals tested annually with a serological test for the granting or for the maintenance of the status and number of ovine or caprine animals tested;

(d)

number of establishments with suspicion following the testing referred to in point (c);

(e)

number of ovine or caprine animals introduced in an establishment referred to in point (a);

(f)

number of ovine or caprine animals tested with a serological test in the context of their introduction into an establishment;

(g)

number of establishments with suspicion following the testing referred to in point (f);

(h)

number of establishments confirmed infected among those referred in points (d) and (g);

(i)

number of establishments with investigations for abortions cases that may have been caused by infection with Brucella abortus, B. melitensis and B. suis;

(j)

number of establishments confirmed infected among those referred in point (i);

(k)

total number of establishments confirmed infected if different from the sum of those reported in points (h) and (j);

(l)

date of last vaccination against infection with Brucella abortus, B. melitensis and B. suis of kept ovine and caprine animals;

(m)

number of establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 and number of ovine or caprine animals kept in these establishments at 31 December;

3.

in case of eradication programmes for infection with MTBC, by zone or region, if more than one region is included in the territorial scope of the programme:

(a)

number of establishments keeping bovine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 and number of bovine animals kept in these establishments at 31 December;

(b)

number of establishments keeping bovine animals with the status free from infection with MTBC including establishments with suspended disease-free status and number of bovine animals kept in these establishments at 31 December;

(c)

number of establishments keeping bovine animals tested during the year for the granting or for the maintenance of the status and number of bovine animals tested for each of the following testing regime as provided for in Section 2 of Chapter 1 of Part II of Annex IV to Delegated Regulation (EU) 2020/689:

(i)

testing required every 12 months;

(ii)

testing required every 24 months;

(iii)

testing required every 36 months;

(iv)

testing required every 48 months;

(d)

number of establishments with suspicion following the testing referred to in point (c);

(e)

number of bovine animals introduced in an establishment referred to in point (a);

(f)

number of bovine animals tested in the context of their introduction in an establishment;

(g)

number of establishments with suspicion following the testing referred to in point (f);

(h)

number of establishments confirmed infected among those referred in points (d) and (g);

(i)

number of bovine animals sent to slaughterhouse from an establishment with the status free from infection with MTBC;

(j)

number of bovine animals slaughtered, among those referred in point (i), presenting suspected lesions of infection with MTBC that have been investigated;

(k)

number of bovine animals, among those referred in point (j), confirmed infected;

(l)

total number of establishments confirmed infected following detection of a suspected lesion at the slaughterhouse;

(m)

total number of establishments confirmed infected if different from the sum of those reported in points (h) and (l);

(n)

number of establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 and number of bovine animals kept in these establishments at 31 December;

4.

in case of eradication programmes for EBL, by zone or region, if more than one region is included in the territorial scope of the programme:

(a)

number of establishments keeping bovine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 and number of bovine animals kept in these establishments at 31 December;

(b)

number of establishments with the status free from EBL including establishments with suspended disease-free status and number of bovine animals kept in these establishments at 31 December;

(c)

number of establishments that have been the granted the status free from EBL and number of bovine animals tested in these establishments;

(d)

number of establishments tested for the maintenance of the status free from EBL and number of bovine animals tested in these establishments;

(e)

number of establishments referred to in point (c) and number of establishments referred to in point (d) with one or more suspected case(s);

(f)

number of establishments and number of bovine animals referred to in point (c) with confirmed cases following the investigation of the suspected case(s) referred to in point (e);

(g)

number of establishments and number of bovine animals referred to in point (d) with confirmed cases following the investigation of the suspected case(s) referred to in point (e) including number of confirmed cases;

(h)

number of bovine animals over 24 months of age that have been slaughtered;

(i)

number of suspected cases that have been identified in the context of the official post-mortem examination of the animals referred to in point (h) and that have been investigated to confirm or rule out the presence of EBL;

(j)

number of confirmed cases following the examination referred to in point (i) of bovine animals that have been kept in an establishment;

(k)

number of establishments with one or more confirmed cases at 31 December;

(l)

number of establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 and number of bovine animals kept in these establishments at 31 December;

5.

in case of eradication programmes for IBR/IPV, by zone or region, if more than one region is included in the territorial scope of the programme:

(a)

number of establishments keeping bovine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 and number of bovine animals kept in these establishments at 31 December;

(b)

number of establishments with the status free from IBR/IPV including establishments with suspended disease-free status and number of bovine animals kept in these establishments at 31 December;

(c)

number of establishments that have been granted the status free from IBR/IPV and number of bovine animals tested in these establishments;

(d)

number of establishments tested for the maintenance of the status free from IBR/IPV and number of bovine animals tested in these establishments by testing regimes provided for in Section 2 of Chapter 1 of Part IV of Annex IV to Delegated Regulation (EU) 2020/689;

(e)

number of establishments with confirmed cases including the number of confirmed cases;

(f)

number of establishments referred to in points (a) and (b) keeping differentiating infected from vaccinated animals (DIVA) vaccinated bovine animals and number of DIVA vaccinated animals kept in these establishments at 31 December;

(g)

number of bovine animals that have been DIVA vaccinated during the reporting period;

(h)

where appropriate, date of last vaccination against IBR/IPV of kept bovine animals;

(i)

number of establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 and number of bovine animals kept in these establishments at 31 December;

6.

in case of eradication programmes for infection with ADV, by zone or region, if more than one region is included in the territorial scope of the programme:

(a)

number of establishments keeping porcine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689, and number of porcine animals kept in these establishments at 31 December;

(b)

number of establishments with the status free from infection with ADV including establishments with suspended disease-free status and number of porcine animals kept in these establishments at 31 December;

(c)

number of establishments that have been granted the status free from infection with ADV and number of porcine animals tested in these establishments;

(d)

number of establishments tested for the maintenance of the status free from infection with ADV and number of porcine animals tested in these establishments;

(e)

number of establishments with clinical, virological or serological evidence of infection with ADV;

(f)

number of establishments with confirmed cases at 31 December;

(g)

number of establishments referred to in point (a) carrying out DIVA vaccination and number of porcine animals that have been DIVA vaccinated;

(h)

where appropriate, date of last vaccination against ADV of kept porcine animals;

(i)

number of establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 and number of porcine animals kept in these establishments at 31 December;

7.

in case of eradication programmes for BVD, by zone or region, if more than one region is included in the territorial scope of the programme:

(a)

number of establishments keeping bovine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 and number of bovine animals kept in these establishments at 31 December;

(b)

number of establishments with the status free from BVD including establishments with suspended disease-free status and number of bovine animals kept in these establishments at 31 December;

(c)

number of establishments with the status free from BVD in accordance with point 2(b) of Section 1 of Chapter 1 of Part VI of Annex IV to Delegated Regulation (EU) 2020/689 which have the status free from BVD maintained in accordance with point 2 of Section 2 of Chapter 1 of Part VI of Annex IV to that Delegated Regulation and number of bovine animals kept in these establishments at 31 December;

(d)

number of establishments that have been granted the status free from BVD and number of bovine animals tested in these establishments;

(e)

number of establishments tested for the maintenance of the status free from BVD and number of bovine animals tested in these establishments;

(f)

number of establishments with confirmed cases at 31 December including the number of confirmed cases;

(g)

number of establishments with confirmed cases epidemiologically linked to the introduction of animals;

(h)

number of establishments where kept bovine animals are vaccinated against BVD and number of vaccinated animals;

(i)

where appropriate, date of last vaccination against BVD of kept bovine animals;

(j)

number of establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 and number of bovine animals kept in these establishments at 31 December;

8.

in case of eradication programmes for infection with RABV, by zone or region, if more than one region is included in the territorial scope of the programme, information on:

(a)

surveillance, including at least maps with data of:

(i)

indicator animals tested per species;

(ii)

confirmed cases by species;

(b)

vaccination of wild animals:

(i)

number and dates of vaccination campaigns;

(ii)

vaccine bait density achieved per zone or region and, if the total size of the vaccination area per vaccination campaign is greater than 20 000 km², vaccine bait density maps;

(iii)

upon request of the Commission, electronic files with:

• flight routes recorded during the vaccine bait distribution,

• vaccine bait distribution: time and position of each bait released recorded during aerial distribution if the total size of the vaccination area per vaccination campaign is greater than 20 000 km²;

(iv)

monitoring of the effectiveness of the vaccination, with maps with data of:

• number of animals positive to the biomarker test/number of biomarker tests performed,

• number of animals positive to serological tests/number of serological tests;

(v)

number and results of the titration of the vaccine baits tests performed;

(c)

number of confirmed cases for which infection with RABV did not occur in the territory concerned (imported cases);

(d)

if epidemiological links in cases referred to in point (c) have been identified, the results of increased surveillance carried out over a period of 6 months following the death of the animal concerned, where relevant;

9.

in case of eradication programmes for infection with BTV:

(a)

territorial scope with a map and a description and demarcation of the geographical and administrative areas covered by the eradication programme and the names of the zones and regions, if more than one region is included in the territorial scope of the programme; where relevant, the reasons for applying the derogation provided for in Article 37(3) of Delegated Regulation (EU) 2020/689 and evolution of the zone during the programme;

(b)

the number of establishments keeping animals of the targeted animal population on 31 December;

(c)

the number of animals of the targeted animal population kept in the establishments referred to in point (b) on 31 December;

(d)

sampling schemes implemented annually: mapping unit and selection criteria implemented, frequency of testing, number of tests, type of diagnostic methods and results;

(e)

number of confirmed cases by zone, species, year/months and BTV serotype(s);

(f)

number of animals vaccinated by year, species and BTV serotype(s);

(g)

derogations for movements granted, number of animals concerned and, where relevant, adaptation of the surveillance implemented;

(h)

coordinated measures with other Member States or third countries, where relevant, and adaptation of the surveillance to external sources of infection with BTV;

10.

in case of eradication programmes for category B and C diseases of aquatic animals, by zone, compartment, or region, if more than one region is included in the territorial scope:

(a)

number of approved aquaculture establishments and where relevant, the number of registered aquaculture establishments keeping animals of the targeted animal population and sampling points in wild populations, which are included in the eradication programme, as well as maps showing the location of establishments and sampling points in wild populations, at 31 December;

(b)

number of aquaculture establishments and, where relevant, sampling points in wild populations, out of the number of establishments or sampling points referred to in point (a), which are not infected at 31 December;

(c)

number of animal health visits per approved and where relevant, registered aquaculture establishments;

(d)

number of samplings per approved and where relevant, registered aquaculture establishments or sampling points in wild populations, as well as details of species, results of sampling (positive/negative) and water temperature at the time of sampling;

(e)

number of infected aquaculture establishments and, where relevant, sampling points in wild populations with confirmed case(s) out of the number of establishments referred to in point (a) at 31 December;

(f)

number of new infected aquaculture establishments and, where relevant, sampling points in wild populations with confirmed case(s) out of the number of establishments referred to in point (a) at 31 December.

ANNEX VII U.K. INFORMATION REQUIRED FOR THE SUBMISSION OF ERADICATION PROGRAMMES IN ACCORDANCE WITH ARTICLE 10

SECTION 1 U.K. Submission of eradication programmes for category B and C diseases of terrestrial animals based on granting disease-free status at the level of establishments

Information to be included in eradication programmes for category B and C diseases of terrestrial animals based on granting of the disease-free status at the level of establishments:

1.

Date of submission.

2.

Name of the country.

3.

Name of disease.

4.

Territorial scope with a description and demarcation of the geographical and administrative areas covered by the eradication programme and the names of the zones and regions, if more than one region is included in the territorial scope of the programme.

5.

A description of the epidemiological situation for each zone or region, if more than one region is included in the territorial scope of the programme:

(a)

the number of establishments keeping animals of the targeted animal population by health status(3) excluding establishments falling under the derogation referred to in point (6)(f) at 31 December;

(b)

the number of animals of the targeted animal population kept in the establishments referred to in point (a) by health status;

(c)

maps indicating the density of the targeted animal population referred to in point (b) by health status;

(d)

timeline with prevalence, incidence data and, where relevant, vaccination history covering at least the past 5 years; and

(e)

information as regards the epidemiological situation in additional animal populations, where relevant.

6.

A description of the disease control strategy of the eradication programme in accordance with Article 16 of Commission Delegated Regulation (EU) 2020/689 including at least:

(a)

the sampling schemes and diagnostic methods to be used in accordance with Annex IV to Delegated Regulation (EU) 2020/689:

(i)

for the granting of the disease-free status to establishments and the maintenance of that status;

(ii)

to confirm or rule out the disease in the event of a suspected case;

(b)

the disease control measures to be applied in the event of a confirmed case;

(c)

the biosecurity and risk mitigating measures to be implemented;

(d)

type of vaccine(s) to be used and the vaccination scheme, if relevant;

(e)

the measures to be implemented as regards additional animal populations, if relevant;

(f)

the derogations to be applied in accordance with Article 19 of Delegated Regulation (EU) 2020/689, if relevant;

(g)

coordinated measures with other Member States or third countries, if relevant.

7.

A description of the organisation, supervision and roles of the parties involved in the eradication programme including at least:

(a)

the authorities in charge of coordinating and supervising the implementation of the programme;

(b)

responsibilities of all stakeholders involved.

8.

The estimated duration of the eradication programme.

9.

The intermediate targets of the eradication programme including at least:

(a)

the expected annual decrease of the number of infected establishments;

(b)

the expected annual increase of the number of disease-free establishments;

(c)

the expected vaccination coverage, where relevant.

SECTION 2 U.K. Submission of eradication programmes for infection with RABV

Information to be included in eradication programmes for infection with RABV:

1.

Date of submission.

2.

Name of the country.

3.

Territorial scope with a description and demarcation of the geographical and administrative areas covered by the eradication programme and names of zones and regions, if more than one region is included in the territorial scope of the programme.

4.

A description of the epidemiological situation during at least the past 5 years, including:

(a)

number of confirmed cases by listed animal species;

(b)

maps indicating the distribution of confirmed cases referred to in point (a) per year;

(c)

disease control strategy and results of control measures.

5.

A description of the disease control strategy of the eradication programme in accordance with Article 32 of Commission Delegated Regulation (EU) 2020/689:

(a)

surveillance, including at least:

(i)

targeted animal population;

(ii)

sampling schemes and details on the collection of dead animals;

(iii)

diagnostic methods;

(b)

if relevant, vaccination, including at least:

(i)

vaccination of kept animals in the framework of the eradication programme;

• type of vaccine(s) to be used,

• targeted population;

(ii)

vaccination of wild animals:

• definition/demarcation of the vaccination area,

• frequency and expected dates of the vaccination campaigns,

• vaccine bait(s) to be used;

• vaccine bait distribution method and designed vaccine bait density;

• description of the methods to be used to assess the correct vaccine bait distribution,

• description of the strategy to monitor the effectiveness of the vaccination as regards serology and vaccine bait uptake in the targeted animal population, the sampling schemes, with details on the collection of dead animals, and diagnostic methods,

• description of the measures to ensure the maintenance of the quality of the vaccine bait before it is distributed particularly as regards titration of the vaccine baits and controls of the cold chain,

• vaccination of stray dogs with the type of vaccine(s) to be used and the targeted population;

(c)

the disease control measures to be applied in the event of a confirmed case;

(d)

the public information campaigns to be implemented;

(e)

the measures to be implemented to reduce the contact with infected animals;

(f)

the coordinated measures with other Member States or third countries, where relevant.

6.

A description of the organisation, supervision and roles of the parties involved in the eradication programme including at least:

(a)

the authorities in charge of coordinating and supervising the implementation of the programme;

(b)

responsibilities of all stakeholders involved.

7.

The estimated duration of the eradication programme.

8.

The intermediate targets of the eradication programme including at least:

(a)

the expected annual decrease of the number of outbreaks;

(b)

the expected number of confirmed outbreaks in areas with outbreaks during the previous year;

(c)

the expected percentage of sero-conversion in targeted animal populations;

(d)

the expected percentage of vaccine uptake in animals of the targeted species.

SECTION 3 U.K. Submission of eradication programmes for infection with BTV

Information to be included in eradication programmes for infection with BTV:

1.

Date of submission.

2.

Name of the country.

3.

Territorial scope with a description and demarcation of the geographical and administrative areas covered by the eradication programme and the names of the zones and regions, if more than one region is included in the territorial scope of the programme: and the reasons for applying the derogation provided for in Article 37(3) of Delegated Regulation (EU) 2020/689, where relevant.

4.

A description of the epidemiological situation for each zone or region, if more than one region is included in the territorial scope of the programme:

(a)

the number of establishments keeping animals of the targeted animal population at 31 December;

(b)

the number of animals of the targeted animal population kept in the establishments referred to in point (a);

(c)

maps indicating:

(i)

the density of the targeted animal population referred to in point (b); and

(ii)

the geographical distribution of cases of infection with BTV by serotypes covering at least the past 5 years;

(d)

timeline with prevalence, incidence data and, where relevant, vaccination history covering at least the past 5 years;

(e)

results of vector surveillance covering at least the past 5 years;

(f)

information as regards the epidemiological situation in additional animal populations, where relevant.

5.

A description of the disease control strategy of the eradication programme in accordance with Article 37 of Delegated Regulation (EU) 2020/689 including at least:

(a)

details of the active surveillance to be implemented in accordance with Section 4 of Chapter 1 of Part II of Annex V to Delegated Regulation (EU) 2020/689 with:

(i)

maps indicating the geographical units;

(ii)

choice of sampling sites, sampling schemes and diagnostic methods used for the monitoring of sentinel animals;

(iii)

choice of sampling sites, sampling schemes and diagnostic methods used for the structured prevalence surveys;

(b)

type of vaccine(s) to be used and vaccination schemes for vaccination of the relevant targeted animal population, where relevant;

(c)

procedure and diagnostic methods to confirm or rule out the disease in the event of a suspected case;

(d)

the disease control measures to be applied in the event of a confirmed case;

(e)

movement restrictions implemented for movements of kept animals and germinal products;

(f)

the biosecurity and risk mitigating measures to be implemented;

(g)

details on vector surveillance and, where relevant, the establishment of seasonally BTV-free areas;

(h)

details on the granting to establishments of the status ‘vector protected establishment’, where relevant;

(i)

coordinated measures with other Member States or third countries, where relevant.

6.

A description of the organisation, supervision and roles of the parties involved in the eradication programme including at least:

(a)

the authorities in charge of coordinating and supervising the implementation of the programme;

(b)

responsibilities of all stakeholders involved.

7.

The estimated duration of the eradication programme.

8.

The intermediate targets of the eradication programme including at least:

(a)

the expected annual decrease of the number of confirmed cases in the targeted animal population;

(b)

the expected annual increase of the number of disease-free geographical units;

(c)

the expected vaccination coverage, where relevant.

SECTION 4 U.K. Submission of eradication programmes for category B and C diseases of aquatic animals

Information to be included in eradication programmes for category B and C diseases of aquatic animals:

1.

Date of submission.

2.

Name of the country.

3.

Name of disease.

4.

Territorial scope with a description and demarcation of the geographical and administrative areas covered by the eradication programme and the names of the zones or compartments.

5.

A description of the epidemiological situation for each zone, compartment or region if more than one region is included in the territorial scope of the programme:

(a)

the number of approved aquaculture establishments and the number of registered aquaculture establishments keeping animals of the targeted animal population, by type of production and by health status(4) at 31 December;

(b)

listed species kept in the aquaculture establishments referred to in point (a) by health status;

(c)

maps indicating:

(i)

the geographical location of the aquaculture establishments referred to in point (a) and the relevant water catchment areas; and

(ii)

the geographical distribution of cases of infection with the relevant category B or C disease covering at least the past 5 years;

(d)

information as regards the epidemiological situation in wild aquatic animals, where relevant.

6.

A description of the disease control strategy of the eradication programme in accordance with Article 46 of Delegated Regulation (EU) 2020/689 including at least:

(a)

the sampling schemes and diagnostic methods to be used in accordance with Annex VI to Delegated Regulation (EU) 2020/689 for:

(i)

health visits and sampling in aquaculture establishments;

(ii)

targeted surveillance in wild populations, where relevant;

(b)

the disease control measures to be applied in the event of a confirmed case;

(c)

the biosecurity and risk mitigating measures to be implemented;

(d)

vaccination schemes, where relevant;

(e)

the measures to be implemented as regards wild aquatic animals and the number and geographical location of sampling points where relevant;

(f)

the derogations to be applied in accordance with Article 53 of Delegated Regulation (EU) 2020/689, where relevant;

(g)

coordinated measures with other Member States or third countries, where relevant.

7.

A description of the organisation, supervision and roles of the parties involved in the eradication programme including at least:

(a)

the authorities in charge of coordinating and supervising the implementation of the programme;

(b)

responsibilities of all stakeholders involved.

8.

The estimated duration of the eradication programme.

9.

The intermediate targets of, and the disease control strategies for implementing, the eradication programme including at least:

(a)

the expected annual decrease of the number of infected aquaculture establishments and where relevant, sampling points in wild populations;

(b)

the expected annual increase of the number of aquaculture establishments and, where relevant, sampling points in wild populations that tested negative;

(c)

the expected vaccination coverage, where relevant.

(1)

Commission Delegated Regulation (EU) 2020/689 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for surveillance, eradication programmes, and disease-free status for certain listed and emerging diseases (OJ L 174, 3.6.2020, p. 211).

(2)

Infected, non-infected, unknown.

(3)

Disease-free, infected or unknown.

(4)

Not-infected, infected, unknown.